Clinical Trial

Comparison of MIPPED-C and Surgical Necrosectomy in Pancreatic Necrosis Outcomes

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated July 31, 2025 (before its estimated December 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study is a retrospective, single-center, pre-post controlled clinical study. Patients (n=48) who underwent the MIPPED-C surgical procedure after January 1, 2019 were designated as the treatment group. Patients who were admitted to the hospital from January 1, 2014 to December 31, 2018 and underwent traditional open surgery were retrospectively evaluated by surgeons, radiologists, and interventionalists, and then matched for propensity score with a 1:2 ratio. 96 patients who underwent traditional open surgery were selected as the control group. The treatment group underwent the MIPPED-C surgery, while the control group underwent the traditional open necrotic tissue debridement procedure. The differences in inflammatory indicators, SIRS response, immune indicators, organ function indicators, and imaging changes of the two groups of patients at the time of admission, before the operation, and after the operation were retrospectively collected. The survival status, postoperative complications, re-intervention status, hospital stay, ICU stay, and hospitalization costs of the two groups of patients after the operation were also collected.
Trial Details
NCT Number NCT07097753
Lead Sponsor Ruijin Hospital
Conditions Acute Pancreatitis (AP), Acute Pancreatitis With Infected Necrosis
Enrollment 144 participants
Start Date 2025-06-01
Primary Completion 2025-12-01 (estimated)
Study Completion 2026-06-01 (estimated)
Updated on ClinicalTrials.gov 2025-07-31